AI Alone Won’t Transform U.S. Healthcare

AI Alone Won’t Transform U.S. Healthcare

AI has the potential to revolutionize healthcare by providing personalized treatment plans, streamlining clinical trials, and aiding in the development of novel therapeutics. However, AI alone cannot fix the flaws in the U.S. healthcare system; it will require serious structural reforms. There are three priorities: accelerate the shift from fee-for-service to value-based care, and integrate AI in the next generation of value-based care strategie…

Why People, Not Just Technology, Will Determine the Success of AI in Healthcare - Hunt Scanlon Media

Introducing new technologies—especially those driven by AI—can disrupt established workflows, challenge existing roles, and strain organizational relationships in unforeseen ways. As a result, the most successful healthcare organizations will be those that look beyond the promise of the tools themselves and focus on how people interact with them, according to a recent report from human capital advisory firm FMG Leading. Understanding the human s…

How AI Is Supporting Hospitals’ Operating Rooms – RamaOnHealthcare

Health systems are finding ways to use artificial intelligence to keep surgical delays to a minimum.Hospitals know too well that surgical delays aren’t good for patient outcomes. They can also negatively impact patient satisfaction and drive up treatment costs.“Imagine getting a life-changing diagnosis, and you need to get into the operating room,” says Kathleen Ulrich, [...]

How AI Can Act as the Lifeline that Counteracts FDA Staffing and Funding Shortages

In the evolving world of healthcare, the U.S. Food and Drug Administration (FDA) plays a vital role as the gatekeeper of public safety—evaluating and approving new therapeutics before they reach patients. But in recent years, the agency has been hamstrung by a troubling combination of staffing and funding shortages. The result? A mounting backlog of drug applications, slower regulatory timelines, and escalating development costs for innovators. …